Sunovion Knocks Out 5 Patents In Mylan's Brovana Suit

Law360, New York (March 2, 2012, 6:58 PM EST) -- Mylan Inc. on Friday vowed to appeal after a New York federal judge ruled that five patents asserted against Sunovion Pharmaceuticals Inc. in a suit over the chronic pulmonary obstructive disease drug Brovana were invalid, and limited potential damages on the two other patents-in-suit.

U.S. District Judge John Koeltl signed off on a 43-page opinion and order granting a motion for partial summary judgment from Dainippon Sumitomo Pharma Co. Ltd. unit Sunovion, concluding that the second of two families of patents being asserted by Mylan and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.